In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement

Michiyo Honda, Toshiisa Konishi, Minori Mizumoto, Mamoru Aizawa

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Cancers frequently metastasize to bone, where it leads to secondary tumor growth, and osteolytic bone degradation. Bone metastases are often associated with fractures and severe pain resulting in decreased quality of life. Accordingly, effective therapies to inhibit the development or progression of bone metastases will have important clinical benefits. Bone cement, one of the powerful tools as bone substitutes, is used to fill the resection voids. The aim of this study was to develop a local drug delivery system using HAp cement as a carrier of chemotherapeutic agents. In the present study, we have fabricated "chelate-setting apatite cements (IP6-HAp cements)" using HAp particles surface-modified with inositol hexaphosphate (IP6) and evaluated their anti-tumor effect. Human osteosarcoma (HOS) cultured on IP6-HAp cements (over 3000 ppm IP6) resulted in inhibition of cell growth. DNA microarray analysis indicated changes in the expression of apoptosis-related genes on IP6-HAp cement surface-modified with 5000 ppm IP6 compared with HAp cement, suggesting activation of apoptosis machinery by IP6-HAp cement. To clarify the mechanism of anti-tumor effect of IP6-HAp cement, the properties of cement were investigated. The release kinetics of IP6 from IP6-HAp cement showed that the level of released IP6 was insufficient to induce anti-tumor activity. These results led us to consider that locally high concentration of IP6 which was released from cement acts on the cells directly as anti-tumor agent and induces the apoptosis. Consequently, IP6-HAp cement might gain the anti-tumor effect and act as a carrier for local drug delivery system.

Original languageEnglish
Title of host publicationKey Engineering Materials
Pages173-177
Number of pages5
Volume529-530
Edition1
DOIs
Publication statusPublished - 2013
Externally publishedYes
Event24th Symposium and Annual Meeting of International Society for Ceramics in Medicine, ISCM 2012 - Fukuoka, Japan
Duration: Oct 21 2012Oct 24 2012

Publication series

NameKey Engineering Materials
Number1
Volume529-530
ISSN (Print)10139826

Other

Other24th Symposium and Annual Meeting of International Society for Ceramics in Medicine, ISCM 2012
CountryJapan
CityFukuoka
Period10/21/1210/24/12

Fingerprint

Bone cement
Hydroxyapatite
Tumors
Cements
Bone
Cell death
Apoptosis
hydroxyapatite cement
Bone Substitutes
Apatites
Bone Cements
Phytic Acid
Apatite
Cell growth
Microarrays
Machinery
DNA
Genes

Keywords

  • Anti-tumor
  • Apoptosis
  • Cement
  • Hydroxyapatite
  • Inositol hexaphosphate

ASJC Scopus subject areas

  • Materials Science(all)
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Honda, M., Konishi, T., Mizumoto, M., & Aizawa, M. (2013). In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement. In Key Engineering Materials (1 ed., Vol. 529-530, pp. 173-177). (Key Engineering Materials; Vol. 529-530, No. 1). https://doi.org/10.4028/www.scientific.net/KEM.529-530.173

In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement. / Honda, Michiyo; Konishi, Toshiisa; Mizumoto, Minori; Aizawa, Mamoru.

Key Engineering Materials. Vol. 529-530 1. ed. 2013. p. 173-177 (Key Engineering Materials; Vol. 529-530, No. 1).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Honda, M, Konishi, T, Mizumoto, M & Aizawa, M 2013, In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement. in Key Engineering Materials. 1 edn, vol. 529-530, Key Engineering Materials, no. 1, vol. 529-530, pp. 173-177, 24th Symposium and Annual Meeting of International Society for Ceramics in Medicine, ISCM 2012, Fukuoka, Japan, 10/21/12. https://doi.org/10.4028/www.scientific.net/KEM.529-530.173
Honda M, Konishi T, Mizumoto M, Aizawa M. In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement. In Key Engineering Materials. 1 ed. Vol. 529-530. 2013. p. 173-177. (Key Engineering Materials; 1). https://doi.org/10.4028/www.scientific.net/KEM.529-530.173
Honda, Michiyo ; Konishi, Toshiisa ; Mizumoto, Minori ; Aizawa, Mamoru. / In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement. Key Engineering Materials. Vol. 529-530 1. ed. 2013. pp. 173-177 (Key Engineering Materials; 1).
@inproceedings{bed97d5863994b8e90297de37c94e222,
title = "In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement",
abstract = "Cancers frequently metastasize to bone, where it leads to secondary tumor growth, and osteolytic bone degradation. Bone metastases are often associated with fractures and severe pain resulting in decreased quality of life. Accordingly, effective therapies to inhibit the development or progression of bone metastases will have important clinical benefits. Bone cement, one of the powerful tools as bone substitutes, is used to fill the resection voids. The aim of this study was to develop a local drug delivery system using HAp cement as a carrier of chemotherapeutic agents. In the present study, we have fabricated {"}chelate-setting apatite cements (IP6-HAp cements){"} using HAp particles surface-modified with inositol hexaphosphate (IP6) and evaluated their anti-tumor effect. Human osteosarcoma (HOS) cultured on IP6-HAp cements (over 3000 ppm IP6) resulted in inhibition of cell growth. DNA microarray analysis indicated changes in the expression of apoptosis-related genes on IP6-HAp cement surface-modified with 5000 ppm IP6 compared with HAp cement, suggesting activation of apoptosis machinery by IP6-HAp cement. To clarify the mechanism of anti-tumor effect of IP6-HAp cement, the properties of cement were investigated. The release kinetics of IP6 from IP6-HAp cement showed that the level of released IP6 was insufficient to induce anti-tumor activity. These results led us to consider that locally high concentration of IP6 which was released from cement acts on the cells directly as anti-tumor agent and induces the apoptosis. Consequently, IP6-HAp cement might gain the anti-tumor effect and act as a carrier for local drug delivery system.",
keywords = "Anti-tumor, Apoptosis, Cement, Hydroxyapatite, Inositol hexaphosphate",
author = "Michiyo Honda and Toshiisa Konishi and Minori Mizumoto and Mamoru Aizawa",
year = "2013",
doi = "10.4028/www.scientific.net/KEM.529-530.173",
language = "English",
isbn = "9783037855171",
volume = "529-530",
series = "Key Engineering Materials",
number = "1",
pages = "173--177",
booktitle = "Key Engineering Materials",
edition = "1",

}

TY - GEN

T1 - In vitro biological evaluation of anti-tumor effect of the chelate-setting hydroxyapatite cement

AU - Honda, Michiyo

AU - Konishi, Toshiisa

AU - Mizumoto, Minori

AU - Aizawa, Mamoru

PY - 2013

Y1 - 2013

N2 - Cancers frequently metastasize to bone, where it leads to secondary tumor growth, and osteolytic bone degradation. Bone metastases are often associated with fractures and severe pain resulting in decreased quality of life. Accordingly, effective therapies to inhibit the development or progression of bone metastases will have important clinical benefits. Bone cement, one of the powerful tools as bone substitutes, is used to fill the resection voids. The aim of this study was to develop a local drug delivery system using HAp cement as a carrier of chemotherapeutic agents. In the present study, we have fabricated "chelate-setting apatite cements (IP6-HAp cements)" using HAp particles surface-modified with inositol hexaphosphate (IP6) and evaluated their anti-tumor effect. Human osteosarcoma (HOS) cultured on IP6-HAp cements (over 3000 ppm IP6) resulted in inhibition of cell growth. DNA microarray analysis indicated changes in the expression of apoptosis-related genes on IP6-HAp cement surface-modified with 5000 ppm IP6 compared with HAp cement, suggesting activation of apoptosis machinery by IP6-HAp cement. To clarify the mechanism of anti-tumor effect of IP6-HAp cement, the properties of cement were investigated. The release kinetics of IP6 from IP6-HAp cement showed that the level of released IP6 was insufficient to induce anti-tumor activity. These results led us to consider that locally high concentration of IP6 which was released from cement acts on the cells directly as anti-tumor agent and induces the apoptosis. Consequently, IP6-HAp cement might gain the anti-tumor effect and act as a carrier for local drug delivery system.

AB - Cancers frequently metastasize to bone, where it leads to secondary tumor growth, and osteolytic bone degradation. Bone metastases are often associated with fractures and severe pain resulting in decreased quality of life. Accordingly, effective therapies to inhibit the development or progression of bone metastases will have important clinical benefits. Bone cement, one of the powerful tools as bone substitutes, is used to fill the resection voids. The aim of this study was to develop a local drug delivery system using HAp cement as a carrier of chemotherapeutic agents. In the present study, we have fabricated "chelate-setting apatite cements (IP6-HAp cements)" using HAp particles surface-modified with inositol hexaphosphate (IP6) and evaluated their anti-tumor effect. Human osteosarcoma (HOS) cultured on IP6-HAp cements (over 3000 ppm IP6) resulted in inhibition of cell growth. DNA microarray analysis indicated changes in the expression of apoptosis-related genes on IP6-HAp cement surface-modified with 5000 ppm IP6 compared with HAp cement, suggesting activation of apoptosis machinery by IP6-HAp cement. To clarify the mechanism of anti-tumor effect of IP6-HAp cement, the properties of cement were investigated. The release kinetics of IP6 from IP6-HAp cement showed that the level of released IP6 was insufficient to induce anti-tumor activity. These results led us to consider that locally high concentration of IP6 which was released from cement acts on the cells directly as anti-tumor agent and induces the apoptosis. Consequently, IP6-HAp cement might gain the anti-tumor effect and act as a carrier for local drug delivery system.

KW - Anti-tumor

KW - Apoptosis

KW - Cement

KW - Hydroxyapatite

KW - Inositol hexaphosphate

UR - http://www.scopus.com/inward/record.url?scp=84871275346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871275346&partnerID=8YFLogxK

U2 - 10.4028/www.scientific.net/KEM.529-530.173

DO - 10.4028/www.scientific.net/KEM.529-530.173

M3 - Conference contribution

SN - 9783037855171

VL - 529-530

T3 - Key Engineering Materials

SP - 173

EP - 177

BT - Key Engineering Materials

ER -